United States - English - NLM (National Library of Medicine)

stat rx usa llc - propranolol hydrochloride (unii: f8a3652h1v) (propranolol - unii:9y8nxq24vq) - propranolol hydrochloride 10 mg - propranolol hydrochloride is a synthetic beta-adrenergic receptor blocking agent chemically described as (±)-1-(isopropylamino)-3-(1-naphthyloxy)-2- propanol hydrochloride. its structural formula is:      structure image propranolol hydrochloride is a stable, white crystalline solid which is readily soluble in water and ethanol. propranolol hydrochloride is available as 10 mg, 20 mg, 40 mg and 80 mg tablets for oral administration. propranolol hydrochloride tablets usp 10 mg, 20 mg, 40 mg, and 80 mg contain the following inactive ingredients: anhydrous lactose, colloidal silicon dioxide, croscarmellose sodium, d and c yellow no. 10, magnesium stearate, microcrystalline cellulose and stearic acid. propranolol hydrochloride tablets usp 10 mg and 80 mg also contain fd and c yellow no. 6. propranolol hydrochloride tablets usp 20 mg and 40 mg also contain fd and c blue no. 1. propranolol is a nonselective beta-adrenergic receptor blocking agent possessing no other autonomic nervous system activity. it s

Malta - English - Medicines Authority

syri pharma limited floor 0 1 wml, 1 windmill lane dublin 2, d02 f206, ireland - propranolol hydrochloride - oral solution - propranolol hydrochloride 5 mg/5ml - beta blocking agents

Malta - English - Medicines Authority

syri pharma limited floor 0 1 wml, 1 windmill lane dublin 2, d02 f206, ireland - propranolol hydrochloride - oral solution - propranolol hydrochloride 10 mg/5ml - beta blocking agents

Malta - English - Medicines Authority

syri pharma limited floor 0 1 wml, 1 windmill lane dublin 2, d02 f206, ireland - propranolol hydrochloride - oral solution - propranolol hydrochloride 40 mg/5ml - beta blocking agents

Malta - English - Medicines Authority

syri pharma limited floor 0 1 wml, 1 windmill lane dublin 2, d02 f206, ireland - propranolol hydrochloride - oral solution - propranolol hydrochloride 50 mg/5ml - beta blocking agents

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - propranolol hydrochloride, quantity: 160 mg - capsule, modified release - excipient ingredients: gelatin; maize starch; sucrose; shellac; purified talc

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - propranolol hydrochloride, quantity: 40 mg - tablet - excipient ingredients: povidone; sodium starch glycollate; lactose monohydrate; quinoline yellow; magnesium stearate; maize starch; sunset yellow fcf aluminium lake; brilliant blue fcf aluminium lake - angina pectoris; hypertension; prevention of migraine; cardiac dysrhythmias: certain intrinsic cardiac dysrhythmias; dysrhythmias associated with thyrotoxicosis; anxiety tachycardia; certain drug-induced dysrhythmias (eg tachycardia due to digitalis or adrenaline overdosage); essential tremor, including familial and senile tremor; phaeochromocytoma (only with concurrent alpha-receptor blockade); hypertrophic subaortic stenosis; suspected or definite myocardial infarction; fallot?s tetralogy

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - propranolol hydrochloride, quantity: 10 mg - tablet - excipient ingredients: lactose monohydrate; maize starch; povidone; sunset yellow fcf aluminium lake; magnesium stearate; quinoline yellow; sodium starch glycollate - angina pectoris; hypertension; prevention of migraine; cardiac dysrhythmias: certain intrinsic cardiac dysrhythmias; dysrhythmias associated with thyrotoxicosis; anxiety tachycardia; certain drug-induced dysrhythmias (eg tachycardia due to digitalis or adrenaline overdosage); essential tremor, including familial and senile tremor; phaeochromocytoma (only with concurrent alpha-receptor blockade); hypertrophic subaortic stenosis; suspected or definite myocardial infarction; fallot?s tetralogy

United States - English - NLM (National Library of Medicine)

american health packaging - propranolol hydrochloride (unii: f8a3652h1v) (propranolol - unii:9y8nxq24vq) - propranolol hydrochloride 60 mg

United States - English - NLM (National Library of Medicine)

pierre fabre pharmaceuticals, inc. - propranolol hydrochloride (unii: f8a3652h1v) (propranolol - unii:9y8nxq24vq) - propranolol hydrochloride 4.28 mg in 1 ml - hemangeol oral solution contains the beta-adrenergic blocker propranolol hydrochloride and is indicated for the treatment of proliferating infantile hemangioma requiring systemic therapy. hemangeol is contraindicated in the following conditions: - premature infants with corrected age < 5 weeks - infants weighing less than 2 kg - known hypersensitivity to propranolol or any of the excipients [see description (11)] - asthma or history of bronchospasm - heart rate <80 beats per minute, greater than first degree heart block, or decompensated heart failure - blood pressure <50/30 mmhg - pheochromocytoma of 460 infants with proliferating infantile hemangioma requiring systemic therapy who were treated with hemangeol starting at 5 weeks to 5 months of age, 60% had complete or nearly complete resolution of their hemangioma at week 24 [see  clinical studies (14)]. safety and effectiveness for infantile hemangioma have not been established in pediatric